Injective Labs
A Litigation Paralegal is sought to join a top plaintiff securities litigation firm, working on high-profile securities class actions and building factual foundations alongside attorneys. The role involves assisting with all phases of litigation, conducting legal and factual research, and managing document review and e-discovery. This position offers a collaborative, mission-driven environment for professionals with a strong background in complex litigation.
Company Size
1-10 employees
Injective Labs is a research and development company focused on creating unmatched Web3 infrastructure and finance solutions, and is one of the core contributors to Injective, a sector-specific Layer 1 blockchain built for finance. The company also contributes to products including Helix, a decentralized orderbook crypto exchange, and Mito, a DeFi protocol featuring strategy vaults and a token launchpad. Additionally, Injective Labs operates advanced validator nodes for promising Web3 projects.
Pineapple launches $100M Injective treasury with $8.9M INJ purchase
Oct 7, 2025
I dropped out of college to build my business. Then Mark Cuban invested in my idea.
Sep 2, 2025
‘Global markets coming on-chain’: Injective bets tokenization will redefine finance
Nov 4, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Injective Labs.
Anh_ba_Cong - COLE(@anh_ba_Cong)'s insights
Oct 7, 2025